Ranked the second-largest U.S. healthcare law firm by Modern Healthcare (2012)
Recognized as a top 10 law firm within the Life Sciences Regulatory Super League by The Practical Law Company (PLC) (2012)
Listed as Recommended in PLC's Life Sciences Multi-Jurisdictional Guide (2012)
honors + affiliations
Past Chair, UNC Pharmacy Foundation
Adjunct Professor, The University of Florida College of Pharmacy
Listed, Life Sciences Star, LMG Life Sciences (2012)
Listed, Chambers USA, Healthcare: Pharmaceutical/Medical Products Regulatory (2012–2013)
Listed, Best Lawyers, FDA Law (2012)
Listed, Super Lawyers
Listed, Washington, D.C. Super Lawyers for FDA (2013)
Recipient, ACRP Global Conference Top Speaker Award (2012)
Recipient, FDLI's Distinguished Service and Leadership Award (1998)
Member, American Society for Pharmacy Law
Member, Association of Food and Drug Officials
Member, District of Columbia Bar Association
Member, Drug Information Association
Member, Federal Bar Association
Member, Regulatory Affairs Professionals Society
International Society for Regulatory Toxicology and Pharmacology
Former Chair, Scholarship Committee of the Food and Drug Law Institute
Editorial Board, Clinical Research Practices and Drug Regulatory Affairs Journal, the Regulatory Toxicology and Pharmacology Journal, the Biomedical and Environmental Sciences Journal, and the FDA Enforcement Manual
Past President, University of North Carolina School of Pharmacy Alumni AssociationReview Board Member, U.S. Adopted Names Council
- District of Columbia
- U.S. Supreme Court
- U.S. District Court for the District of Columbia
- Washington, D.C.
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
Gary L. Yingling is a partner in Morgan Lewis's FDA Practice. Mr. Yingling focuses his practice on issues involving the U.S. Food and Drug Administration (FDA) and has also represented clients in matters involving the U.S. Department of Agriculture Food Safety and Inspection Service, the Environmental Protection Agency, the Consumer Product Safety Commission, the Federal Trade Commission, and various states. His clients have included individuals, partnerships, and corporations in cases involving labeling, importation, regulatory marketing strategy, recalls, seizures, and criminal matters.
Mr. Yingling's work in the food industry involves a variety of matters, including ingredient safety questions and product labeling, and his work in the drug industry ranges from the preparation of Investigational New Drug (IND) applications to product labeling. He also has a particular interest in clinical research, contract research organization, and sponsor matters.
Prior to joining Morgan Lewis, Mr. Yingling was a partner in multiple food and drug practices of international law firms, resident in Washington, D.C. Before entering private practice, he served as president of the Food and Drug Law Institute for nine years. Earlier in his career, Mr. Yingling served in the FDA's office of the general counsel for 10 years, first as a trial attorney and later as associate chief counsel for its Bureau of Veterinary Medicine and as the deputy chief counsel for administration. He was also director of the Over-the-Counter (OTC) Drug Review in the Bureau of Drugs for two years. Mr. Yingling received the FDA's Award of Merit, the agency's highest award, in 1974 for his legal and administrative work on the OTC Review.
Mr. Yingling earned his J.D. from Emory University School of Law in 1968. Prior to attending law school, he practiced community pharmacy and is a registered pharmacist in Maryland and the District of Columbia. He earned his M.S. from Purdue University in 1966 and his B.S. from the University of North Carolina in 1962.
Mr. Yingling is admitted to practice in the District of Columbia and before the U.S. Supreme Court and the U.S. District Court for the District of Columbia.
- Emory University School of Law, 1968, J.D.
- Purdue University, 1966, M.S.
- University of North Carolina, 1962, B.S.